|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-11-28
|
|
pubmed:abstractText |
The clinical efficacy of combination therapy comprising a long acting beta(2)-agonist (LABA) and corticosteroid is widely recognized for the treatment of adult asthma. Here we examine the effect of salmeterol xinafoate (SX) and fluticasone propionate (FP) alone and in combination on the immunological activation of human cultured mast cells (HCMC)in vitro.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-2 Receptor Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Albuterol,
http://linkedlifedata.com/resource/pubmed/chemical/Androstadienes,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Asthmatic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte-Macrophage...,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin E,
http://linkedlifedata.com/resource/pubmed/chemical/Leukotrienes,
http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandin D2,
http://linkedlifedata.com/resource/pubmed/chemical/fluticasone,
http://linkedlifedata.com/resource/pubmed/chemical/salmeterol
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1323-8930
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
55
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
387-93
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17130681-Adrenergic beta-2 Receptor Agonists,
pubmed-meshheading:17130681-Adrenergic beta-Agonists,
pubmed-meshheading:17130681-Albuterol,
pubmed-meshheading:17130681-Androstadienes,
pubmed-meshheading:17130681-Anti-Asthmatic Agents,
pubmed-meshheading:17130681-Anti-Inflammatory Agents,
pubmed-meshheading:17130681-Cells, Cultured,
pubmed-meshheading:17130681-Dose-Response Relationship, Drug,
pubmed-meshheading:17130681-Dose-Response Relationship, Immunologic,
pubmed-meshheading:17130681-Drug Evaluation, Preclinical,
pubmed-meshheading:17130681-Drug Synergism,
pubmed-meshheading:17130681-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:17130681-Histamine Release,
pubmed-meshheading:17130681-Humans,
pubmed-meshheading:17130681-Immunoglobulin E,
pubmed-meshheading:17130681-Leukotrienes,
pubmed-meshheading:17130681-Mast Cells,
pubmed-meshheading:17130681-Prostaglandin D2
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Effects of salmeterol xinafoate and fluticasone propionate on immunological activation of human cultured mast cells.
|
|
pubmed:affiliation |
Department of Pharmacology, Gifu Pharmaceutical University, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
